Personalized mRNA cancer vaccine therapy
Personalized mRNA cancer vaccine therapy is a therapy that uses a personalized cancer vaccine based on mRNA vaccine technology to target existing tumors in patients. As of 2024[update], number of mRNA cancer vaccines are in clinical trials, of which many are personalized therapies based on engineering mRNA-mediated immune response that targets the patient's particular strain of cancer cells.[1]
Experimental treatments include treatments for pancreatic cancer, head and neck cancers, and melanoma.[2][3][4]
In 2024, the British National Health Service announced that had launched its Cancer Vaccine Launch Pad, a collaboration for trials for the use of personalized mRNA cancer vaccines on its patients.[5]
References
External links
 | This oncology article is a stub. You can help Wikipedia by expanding it. |
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |